Emmaus Life Sciences amends bylaws to establish exclusive forum for stockholder litigation

Emmaus Life Sciences, Inc.

Board adopted Amendment to Amended and Restated By-Laws on May 23, 2024.
Delaware Chancery Court designated as sole forum for derivative and internal affairs actions.
Federal district courts designated as exclusive forum for Securities Act claims.
Amendment effective immediately; shareholders deemed to have consented.
Exclusive forum provisions apply to actions based on duties, DGCL, and internal affairs.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.